Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 137 Leukemia 64 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Leukemia, Myelomonocytic, Acute 26 Leukemia, Monocytic, Acute 26 Leukemia, Erythroblastic, Acute 23 Leukemia, Megakaryoblastic, Acute 22 Myelodysplastic Syndromes 21 Congenital Abnormalities 19 Leukemia, Promyelocytic, Acute 12 Leukemia, Myelomonocytic, Chronic 11 Anemia, Refractory, with Excess of Blasts 11 Recurrence 8 Myeloproliferative Disorders 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Eosinophilic, Acute 7 Carcinoma, Hepatocellular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Biphenotypic, Acute 6 Leukemia, Basophilic, Acute 6 Lymphoma 5 Neoplasm, Residual 4 Multiple Myeloma 4 Blast Crisis 4 Neutropenia 3 Neoplasms, Plasma Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Liver Neoplasms 3 Leukemia, Myeloid, Accelerated Phase 3 Neoplasms 2

Interventions

Rituximab 97 Cyclophosphamide 93 fludarabine 56 Doxorubicin 29 Vincristine 27 Prednisone 27 Etoposide 25 Lenalidomide 22 ibrutinib 20 fludarabine phosphate 20 obinutuzumab 16 pembrolizumab 15 Bendamustine Hydrochloride 15 Magnetic Resonance Spectroscopy 14 Immunotherapy, Adoptive 14 Cytarabine 13 Specimen Handling 11 CT-P10 11 Bortezomib 11 polatuzumab vedotin 10 Gemcitabine 10 venetoclax 9 pirtobrutinib 9 Nivolumab 9 Carboplatin 9 Biopsy 9 zanubrutinib 8 glofitamab 8 Radiotherapy 8 Ifosfamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00210366 2010-07-30

Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma

International Extranodal Lymphoma Study Group (IELSG)

Phase 2 Terminated

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡